High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma*.
Saved in:
| Title: | High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma*. |
|---|---|
| Authors: | Westphal, D.1,2 (AUTHOR) dana.westphal@uniklinikum-dresden.de, Garzarolli, M.1 (AUTHOR), Sergon, M.3 (AUTHOR), Horak, P.4,5 (AUTHOR), Hutter, B.4,6,7 (AUTHOR), Becker, J.C.8,9 (AUTHOR), Wiegel, M.1 (AUTHOR), Maczey, E.10 (AUTHOR), Blum, S.11 (AUTHOR), Grosche‐Schlee, S.12 (AUTHOR), Rütten, A.13 (AUTHOR), Ugurel, S.8 (AUTHOR), Stenzinger, A.4,14 (AUTHOR), Glimm, H.15,16,17,18 (AUTHOR), Aust, D.2,3,19 (AUTHOR), Baretton, G.2,3,19 (AUTHOR), Beissert, S.1,2 (AUTHOR), Fröhling, S.4,5 (AUTHOR), Redler, S.20 (AUTHOR), Surowy, H.20 (AUTHOR) |
| Source: | British Journal of Dermatology. Dec2021, Vol. 185 Issue 6, p1186-1199. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 154221338 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma*. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Westphal%2C+D%2E%22">Westphal, D.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> dana.westphal@uniklinikum-dresden.de</i><br /><searchLink fieldCode="AR" term="%22Garzarolli%2C+M%2E%22">Garzarolli, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sergon%2C+M%2E%22">Sergon, M.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Horak%2C+P%2E%22">Horak, P.</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hutter%2C+B%2E%22">Hutter, B.</searchLink><relatesTo>4,6,7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Becker%2C+J%2EC%2E%22">Becker, J.C.</searchLink><relatesTo>8,9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wiegel%2C+M%2E%22">Wiegel, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maczey%2C+E%2E%22">Maczey, E.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Blum%2C+S%2E%22">Blum, S.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grosche‐Schlee%2C+S%2E%22">Grosche‐Schlee, S.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rütten%2C+A%2E%22">Rütten, A.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ugurel%2C+S%2E%22">Ugurel, S.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stenzinger%2C+A%2E%22">Stenzinger, A.</searchLink><relatesTo>4,14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Glimm%2C+H%2E%22">Glimm, H.</searchLink><relatesTo>15,16,17,18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aust%2C+D%2E%22">Aust, D.</searchLink><relatesTo>2,3,19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baretton%2C+G%2E%22">Baretton, G.</searchLink><relatesTo>2,3,19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Beissert%2C+S%2E%22">Beissert, S.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fröhling%2C+S%2E%22">Fröhling, S.</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Redler%2C+S%2E%22">Redler, S.</searchLink><relatesTo>20</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Surowy%2C+H%2E%22">Surowy, H.</searchLink><relatesTo>20</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22British+Journal+of+Dermatology%22">British Journal of Dermatology</searchLink>. Dec2021, Vol. 185 Issue 6, p1186-1199. 14p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=154221338 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjd.20604 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 1186 Titles: – TitleFull: High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma*. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Westphal, D. – PersonEntity: Name: NameFull: Garzarolli, M. – PersonEntity: Name: NameFull: Sergon, M. – PersonEntity: Name: NameFull: Horak, P. – PersonEntity: Name: NameFull: Hutter, B. – PersonEntity: Name: NameFull: Becker, J.C. – PersonEntity: Name: NameFull: Wiegel, M. – PersonEntity: Name: NameFull: Maczey, E. – PersonEntity: Name: NameFull: Blum, S. – PersonEntity: Name: NameFull: Grosche‐Schlee, S. – PersonEntity: Name: NameFull: Rütten, A. – PersonEntity: Name: NameFull: Ugurel, S. – PersonEntity: Name: NameFull: Stenzinger, A. – PersonEntity: Name: NameFull: Glimm, H. – PersonEntity: Name: NameFull: Aust, D. – PersonEntity: Name: NameFull: Baretton, G. – PersonEntity: Name: NameFull: Beissert, S. – PersonEntity: Name: NameFull: Fröhling, S. – PersonEntity: Name: NameFull: Redler, S. – PersonEntity: Name: NameFull: Surowy, H. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: Dec2021 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 00070963 Numbering: – Type: volume Value: 185 – Type: issue Value: 6 Titles: – TitleFull: British Journal of Dermatology Type: main |
| ResultId | 1 |